Holen Sie sich die Stockscreener-App
6.46
0.00%
0.00
Schlusskurs vom Vortag:
$6.46
Offen:
$6.69
24-Stunden-Volumen:
89,176
Relative Volume:
0.09
Marktkapitalisierung:
$301.70M
Einnahmen:
$20.72M
Nettoeinkommen (Verlust:
$-100.84M
KGV:
-2.4286
EPS:
-2.66
Netto-Cashflow:
$-78.56M
1W Leistung:
-5.69%
1M Leistung:
+39.22%
6M Leistung:
+42.60%
1J Leistung:
-57.78%
1-Tages-Spanne:
$6.422
$6.73
1-Wochen-Bereich:
$6.385
$7.33
52-Wochen-Spanne:
$2.235
$17.41
4 D Molecular Therapeutics Inc Stock (FDMT) Company Profile
Firmenname
4 D Molecular Therapeutics Inc
Sektor
Branche
Telefon
(510) 505-2680
Adresse
5858 HORTON STREET #455, EMERYVILLE
Vergleichen Sie FDMT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FDMT
4 D Molecular Therapeutics Inc
|
6.46 | 304.97M | 20.72M | -100.84M | -78.56M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.33 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
581.94 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.57 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
703.91 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
299.18 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
4 D Molecular Therapeutics Inc Stock (FDMT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-11-21 | Eingeleitet | Morgan Stanley | Underweight |
| 2024-09-23 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-04-15 | Eingeleitet | Barclays | Overweight |
| 2024-02-07 | Fortgesetzt | Goldman | Buy |
| 2023-10-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-18 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2023-01-30 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-11-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-11-15 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-12 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-06-22 | Eingeleitet | Jefferies | Buy |
| 2022-01-04 | Eingeleitet | SVB Leerink | Outperform |
| 2021-01-05 | Eingeleitet | BofA Securities | Buy |
| 2021-01-05 | Eingeleitet | Evercore ISI | Outperform |
| 2021-01-05 | Eingeleitet | Goldman | Neutral |
Alle ansehen
4 D Molecular Therapeutics Inc Aktie (FDMT) Neueste Nachrichten
Is 4D Molecular Therapeutics Inc. a candidate for recovery play2025 Year in Review & Fast Exit and Entry Strategy Plans - Newser
Combining machine learning predictions for 4D Molecular Therapeutics Inc.Earnings Risk Summary & Expert Curated Trade Ideas - Newser
Published on: 2025-08-28 04:19:38 - Newser
Is this a good reentry point in 4D Molecular Therapeutics Inc.Market Trend Report & Weekly Top Gainers Trade List - Newser
Applying chart zones and confluence areas to 4D Molecular Therapeutics Inc.2025 Support & Resistance & Capital Protection Trading Alerts - Newser
Top chart patterns to watch in 4D Molecular Therapeutics Inc.2025 Technical Overview & Verified Trade Idea Suggestions - Newser
Real time scanner hits for 4D Molecular Therapeutics Inc. explainedBuy Signal & Community Verified Watchlist Alerts - Newser
4D Molecular Therapeutics Inc. stock chart pattern explained2025 Trade Ideas & Verified Short-Term Plans - Newser
Multi asset correlation models including 4D Molecular Therapeutics Inc.2025 Market Overview & Capital Efficiency Focused Strategies - Newser
4D Molecular Therapeutics Inc. stock trendline breakdownMarket Trend Report & Weekly Top Stock Performers List - Newser
Pattern recognition hints at 4D Molecular Therapeutics Inc. upsideJuly 2025 Selloffs & Short-Term High Return Strategies - Newser
Using fundamentals and technicals on 4D Molecular Therapeutics Inc.Bear Alert & Weekly Top Gainers Alerts - Newser
Market reaction to 4D Molecular Therapeutics Inc.’s recent newsEarnings Risk Report & Weekly Watchlist for Consistent Profits - Newser
What indicators show strength in 4D Molecular Therapeutics Inc.Quarterly Profit Summary & Weekly Watchlist of Top Performers - Newser
Is 4D Molecular Therapeutics Inc. meeting your algorithmic filter criteriaMarket Volume Summary & AI Based Buy and Sell Signals - Newser
Will a bounce in 4D Molecular Therapeutics Inc. offer an exitIndex Update & Reliable Intraday Trade Plans - Newser
Can you recover from losses in 4D Molecular Therapeutics Inc.Market Risk Summary & Entry Point Confirmation Alerts - Newser
What institutional flow reveals about 4D Molecular Therapeutics Inc.Market Growth Summary & Capital Protection Trading Alerts - Newser
Predicting 4D Molecular Therapeutics Inc. trend using moving averagesJuly 2025 Summary & Verified Momentum Watchlists - Newser
Price momentum metrics for 4D Molecular Therapeutics Inc. explainedMarket Movement Recap & High Accuracy Buy Signal Tips - Newser
Can trapped investors hope for a rebound in 4D Molecular Therapeutics Inc.2025 Top Gainers & Weekly High Return Stock Forecasts - Newser
What momentum shifts mean for 4D Molecular Therapeutics Inc.Portfolio Return Summary & Low Risk Growth Stock Ideas - Newser
Volatility clustering patterns for 4D Molecular Therapeutics Inc.Trade Ideas & Safe Capital Preservation Plans - Newser
How to escape a deep drawdown in 4D Molecular Therapeutics Inc.2025 Market Overview & Risk Managed Trade Strategies - Newser
4D Molecular Therapeutics shares fall 5.19% premarket despite upcoming investor conferences in September. - AInvest
What technical models suggest about 4D Molecular Therapeutics Inc.’s comebackJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser
4D Molecular Therapeutics Inc. Reversal Rally May Surprise Bears2025 Key Highlights & Technical Entry and Exit Alerts - beatles.ru
Why 4D Molecular Therapeutics Inc. stock attracts strong analyst attention2025 Analyst Calls & Weekly Market Pulse Updates - sisaissue.com
Technical analysis overview for 4D Molecular Therapeutics Inc. stock2025 Key Lessons & Capital Efficiency Focused Strategies - Newser
Relief Rally in 4D Molecular Therapeutics Inc. Stock — Can It Hold2025 Market WrapUp & Free Daily Entry Point Trade Alerts - newsyoung.net
Candlestick Signal Suggests Reversal in 4D Molecular Therapeutics Inc.Analyst Downgrade & Weekly Watchlist of Top Performers - 선데이타임즈
Finanzdaten der 4 D Molecular Therapeutics Inc-Aktie (FDMT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.78%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):